US 11,873,284 B2
Pyridinylcyanoguanidine derivative and use thereof
Zheming Wang, Zhejiang (CN); and Hao Tan, Zhejiang (CN)
Assigned to Zheming Wang, Hangzhou (CN); and Rushi Biotech (Hangzhou) Co., Ltd, Hangzhou (CN)
Filed by Zheming Wang, Hangzhou (CN); and Rushi Biotech (Hangzhou) Co., Ltd, Hangzhou (CN)
Filed on Dec. 13, 2022, as Appl. No. 18/080,723.
Claims priority of application No. 202111580925.4 (CN), filed on Dec. 22, 2021.
Prior Publication US 2023/0192615 A1, Jun. 22, 2023
Int. Cl. C07D 213/75 (2006.01); C07D 401/12 (2006.01); C07D 409/14 (2006.01); C07D 405/12 (2006.01)
CPC C07D 213/75 (2013.01) [C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 409/14 (2013.01)] 3 Claims
 
1. A pyridinylcyanoguanidine derivative or a pharmaceutically acceptable salt thereof, wherein the pyridinylcyanoguanidine derivative has a structure of Formula (XXIII), Formula (XXIV), Formula (XXV) or Formula (XXVI):

OG Complex Work Unit Chemistry
wherein X1 is hydrogen, fluoro, chloro, bromo, iodo or hydroxyl;
X2 is hydrogen, fluoro, chloro, bromo, iodo or hydroxyl; and
Y is a heteroatom selected from the group consisting of nitrogen, oxygen, and sulfur.